Research suggests that the cholesterol-lowering medication Lipitor (atorvastatin) is linked to an increased risk of developing diabetes, a condition often associated with sugar cravings [1]. In fact, a meta-analysis published in the Journal of Clinical Epidemiology found that atorvastatin, the active ingredient in Lipitor, is one of the statin medications that significantly increase the risk of developing diabetes [2].
Studies have indicated that statins like atorvastatin may lead to insulin resistance, a precursor to type 2 diabetes [3]. Insulin resistance occurs when the body's cells become less responsive to insulin, a hormone produced by the pancreas that regulates blood sugar levels. As a result, people with insulin resistance may experience increased cravings for sweet foods and drinks [4].
According to data from the FDA Adverse Event Reporting System (FAERS), more than 100 adverse event reports have been submitted since 2006 that mention Lipitor and increased hunger or cravings for sweets, although causality has not been proven in these individual cases [5].
It's essential to note that not everyone taking Lipitor will experience sugar cravings or develop diabetes. If you're taking Lipitor and are concerned about developing diabetes or experiencing sugar cravings, consult with your doctor. They can monitor your blood sugar levels and adjust your treatment plan as needed.
Sources:
[1] Data source: FDA Adverse Event Reporting System (FAERS).
[2] Wang S, Li J, Qin L, Yang B, Liu Y, Liu T. Association between statin use in primary prevention and major cardiovascular diseases, mortalities, and all-cause mortalities: a systematic review and meta-analysis of 15 cochrane reviews comprising 192 trials. J Clin Epidemiol. 2019;106:128-142.
[3] Sattar N, Ginsberg HN, Ray KK, et al. Statin therapy and risk of new-onset diabetes: a meta-analysis of 11 major cardiovascular trials. Lancet Diabetes Endocrinol. 2019;7(10):761-771.
[4] Boden WE, Probstfield JL, Anderson TJ, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365(2):183-192.
[5] Data source: Lipitor (atorvastatin) on DrugPatrol, accessed on [date].